Hinge Health is trading at $92.15, up 4.02%, outperforming a broader market that is moving lower; no new September 14, 2026 company-specific announcement clearly explains the gain.
- Stifel raised its price target to $115 from $96 while maintaining a Buy rating.
- Hinge Health completed the $105 million Cylinder Health acquisition, but neither development directly attributes the September 14 move; recent CEO and CFO insider selling predates the session and does not explain the rise.